Complement Activity (CH50) | Wako Pure Chemicals Diagnostics
- Top
- Products
HCC Risk Biomarkers
-
- AFP-L3
- PIVKA-II
- μTASWako i30
β-Glucan Test
- Toxinometer MT-6500
- β-Glucan Test
- β-Glucan Test - Information for Health Care Providers
Clinical Diagnostics Reagents
- Enzymes
-
- Aspartate Aminotransferase (AST)
- Alanine Aminotransferase (ALT)
- Alkaline Phosphatase (ALP)
- Lactate Dehydrogenase (LD)
- γ-glutamyl transpeptidase (γ-GT)
- Creatine Phosphokinase (CPK)
- Amylase (AMY)
- Lipase
- Pancreatic Amylase (P-AMY)
- Creatine kinase MB (CK-MB)
- Leucine amino peptidase (LAP)
- Lipids
-
- Triglycerides (TG)
- Total Cholesterol (T-Cho)
- HDL Cholesterol (HDL-C)
- LDL Cholesterol (LDL-C)
- Non-esterified fatty acids (NEFA)
- Phospholipids (PL)
- Nitrogenuous Compounds
-
- Creatinine (CRE)
- Urea Nitrogen (UN)
- Uric Acid (UA)
- Proteins
-
- C-Reactive Protein (CRP)
- Rheumatoid Factor (RF)
- Antistreptolysin O (ASO)
- Ferritin
- Pepsinogen I (PG I)
- Pepsinogen II (PG II)
- Helicobacter Pylori Antibody (H. Pylori)
- Microalbumin (μAlb)
- Total Protein
- Albumin
- Others
-
- Total Bilirubin (T-Bil)
- Direct Bilirubin (D-Bil)
- Complement Activity (CH50)
- 3-hydroxybutyrate (3-HB)
- Total Ketone Bodies (T-KB)
- Calcium (Ca)
- Unsaturated Iron Binding Capacity (UIBC)
- Inorganic Phosphorus (IP)
- Magnesium (Mg)
- Glucose (Glu)
-
- Support
- Package Inserts
- Safety Data Sheets
- Contact Us
- Inquiry
- Worldwide Contacts
- Distributors
- Top
- Products
- HCC Risk Biomarkers
- β-Glucan Test
- Clinical Diagnostics Reagents
Support
- Package Inserts
- Safety Data Sheets
Contact Us
- Inquiry
- Worldwide Contacts
- Distributors
Country / Region
- Japan
- China
- Asia-Pacific
- Europe
Autokit CH50For In Vitro Diagnostic Use
Intended Use
The Autokit CH50 is an in vitro liposome immunoassay for the quantitative determination of total complement activity (CH50) in human serum, using an automated procedure.
Method
Liposome Immunoassay
Special Characteristics
Autokit CH50 is a homogeneous reagent free from precipitation due to small-size liposome (200nm) which gives stable dispersion. This reagent shows high correlation with gold standard, Mayer's method used most widely based on complement-mediated hemolysis of antibody-sensitized erythrocytes. This reagent is designed for general biochemical automated analyzer.
Principle of the Method
When a sample is mixed with the Liposome and Substrate, the antibodies in the reagent combine with dinitrophenyl (DNP) on the liposomes and then complements in the sample are activated by the antigen-antibody complex. The activated complements break the membrane of the liposome. The enzyme, glucose-6-phosphate dehydrogenase (G6PDH) contained in the liposome, reacts with NAD and glucose-6-phosphate (G6P) in the reagent. During this enzyme reaction the NAD is reduced to NADH. As a result of this reduction, absorbance at 340 nm increases. The absorbance increase is proportional to the complement activity in the sample.
Standard Procedure
Application to automated analyzers and Package are available upon request
Ordering Information
| Product | Storage Condition | Shelf Life | |
|---|---|---|---|
| Autokit CH50 | LiposomeSubstrateDiluent | 2-10°CDo not freeze | 12 months |
| Calibrator | Storage Condition | Shelf Life |
|---|---|---|
| CH50 Calibrator | -10°C or lower | 12 months |
| Control | Storage Condition | Shelf Life |
|---|---|---|
| Complement Control | -10°C or lower | 12 months |
This website uses cookies. By using the site you are agreeing to our Privacy Policy.
Từ khóa » Ch50
-
Complement Total (CH50) Blood Test - Walk-In Lab
-
Measuring The 50% Haemolytic Complement (CH50 ... - PubMed
-
Measuring The 50% Haemolytic Complement (CH50) Activity Of Serum
-
Total Complement Activity - Wikipedia
-
Complement, Total (CH50) - Lab Results Explained
-
001941: Complement, Total (CH50) - Labcorp
-
Complement Blood Test: MedlinePlus Medical Test
-
Complement Activity Total, (CH50) | ARUP Laboratories Test Directory
-
Complement, Total (CH50) | Test Detail | Quest Diagnostics
-
CH50 Test Kit - HaemoScan
-
Patients With Covid 19 Have Significantly Reduced CH50 Activity
-
Complement Activity (CH50) - | Fujifilm Healthcare
-
Complement CH50 Or CH100 - RCPA
-
Complement Information - Blood Test - Mount Sinai